LDHzyme-assisted high-performance on-site tracking of levodopa pharmacokinetics for Parkinson's disease management

Parkinson's disease is a progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons, leading to motor and cognitive impairments. Levodopa, the primary treatment, requires precise dosing due to its complex pharmacokinetics and narrow therapeutic window. Levodopa needs to be carefully managed because the right dose can vary from person to person, and taking too much or too little can cause side effects. Traditional methods for monitoring levodopa levels involve blood sampling, which is impractical for real-time management. This study introduces a new technology: a sensor that measures levodopa levels in sweat. The sensor uses advanced materials to detect very small amounts of the drug with high accuracy. It is non-invasive, does not require blood samples, and can monitor levodopa levels continuously in real time. By comparing the sweat levels to blood levels, doctors can track how a person processes the medication and adjust the dose as needed. This sensor could make managing Parkinson’s much easier and safer, allowing for more personalized treatments. Instead of relying on occasional blood tests, doctors would have up-to-the-minute information to ensure patients get the right amount of medication at the right time, improving their quality of life.